Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Low-penetration genes might help personalize colorectal cancer prevention.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

Combining warning symbols with education significantly reduced medication crushing errors in nursing homes.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

The document concludes that the new expert system can assess the risk of PCOS effectively despite uncertainties in diagnosis.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Sulforaphane from broccoli can help protect skin from sun damage.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Public health decisions should rely on independent trials, not biased literature.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Ruxolitinib can cause a delayed skin reaction on the nose.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

RUM-loaded SLN shows promise for treating acne and hair loss topically.